Intravenous Equipment Market By Product Type (IV catheters, Infusion pumps, Administration sets, Needleless connectors, Others), By End User (Hospitals and clinics, Homecare settings, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Intravenous Equipment Market

Intravenous equipment refers to a range of medical devices and accessories used in the administration of fluids, medications, and other treatments directly into a patient's bloodstream through a vein. This equipment is designed to ensure the safe, accurate, and controlled delivery of substances intravenously. Intravenous administration offers advantages such as rapid onset of action, accurate dosage control, and direct delivery to the bloodstream. As a result, there is a growing need for advanced intravenous equipment that can safely and efficiently deliver these drugs.

Key factors driving the growth of the intravenous equipment market are rising prevalence of chronic conditions, rise in geriatric population and increase in surgical procedures. Chronic diseases such as diabetes, cancer and renal diseases, are on the rise globally. These conditions often require long-term management and treatment, leading to an increased demand for intravenous therapies. For instance, cancer patients require continuous IV chemotherapy, thereby driving the demand for intravenous equipment. The rising incidence of these diseases is a significant driver of the intravenous equipment market. In addition, world's population is aging rapidly, particularly in developed countries. With age, the risk of chronic diseases and medical conditions increases. Elderly individuals often require hospitalization and continuous medical support, leading to a higher need for intravenous therapies. The aging population is thus contributing to the growth of the intravenous equipment market. In addition, increasing number of surgical procedures being performed globally has led to a higher demand for intravenous equipment in operating rooms and post-operative care units. IV fluids and medications are commonly used during surgical interventions to maintain patient hydration, provide anesthesia, and manage pain. As surgical volumes increase, so does the requirement for IV equipment.

Further, technological advancements have significantly improved the safety and efficiency of IV administration. For instance, the development of smart infusion pumps with dose error reduction systems (DERS) has minimized the risk of medication errors. Additionally, the integration of wireless communication with IV devices has streamlined workflow, enabling real-time monitoring and automated documentation. These innovations are driving the adoption of advanced IV equipment in healthcare settings. In addition, needleless connectors offer quick and convenient access to IV lines or ports, improving the efficiency of IV therapy. Healthcare providers can easily connect or disconnect syringes or IV tubing without the need for needle punctures. This streamlined process saves time and reduces the risk of accidental needlestick injuries among healthcare workers. Further, to speeding up medication administration, needleless connectors also facilitate the administration of intermittent medications or flushes. The ability to access the IV line without removing the dressing or disrupting the catheter site simplifies the process, enhancing patient comfort and reducing the likelihood of dressing-related complications.

Furthermore, there is a growing trend of shifting healthcare services from hospitals to home settings, driven by cost-effectiveness and patient preference. Home healthcare allows patients to receive treatments comfortably in their homes while reducing the burden on hospitals. Intravenous therapies are increasingly being administered in home settings, and the demand for portable and easy to use IV equipment has risen accordingly. Intravenous therapies are increasingly being administered in home settings for conditions such as chronic pain management, parenteral nutrition, and certain chemotherapy treatments. Portable and easy-to-use IV equipment is in high demand to facilitate home-based treatments effectively. Moreover, rapidly developing healthcare infrastructure in emerging economies has boosted the demand for intravenous equipment. Governments and private healthcare providers are investing heavily in improving medical facilities and expanding access to quality healthcare services. This, coupled with the rising disposable income and healthcare awareness, is driving the adoption of advanced IV equipment in these regions.

The intravenous equipment market is segmented into product type, end user, and region. On the basis of product type, the market is categorized into IV catheters, infusion pumps, administration sets, needleless connectors and others. Further, administration sets are classified into solution administration sets and blood administration sets. On the basis of end user, the market is segregated into hospital and clinics, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). The key players profiled in the study include Gilead Sciences, Inc., Becton, Dickinson and Company, B. Braun SE, ICU Medical, Inc., vygon, Baxter International Inc., Teleflex Incorporated., 3M Company, AngioDynamics, Inc., Terumo Corporation and Poly Medicure Ltd. The key players have adopted strategies such as acquisition and product approval to expand their product portfolio.

Key Market Insights

By product type, the IV catheters segment accounted for largest share in terms of revenue in 2022, and is expected to register highest CAGR during the forecast period.

On the basis of end user, the hospitals and clinics segment accounted for largest share in terms of revenue in 2022. On the other hand, homecare settings segment is anticipated to register highest CAGR during the forecast period.

Region wise, North America occupied the largest share in terms of revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Overview

The intravenous equipment market was valued for $15.0 billion in 2022 and is estimated to reach $26.7 billion by 2032, exhibiting a CAGR of 5.9% from 2023 to 2032.

Intravenous (IV) equipment refers to the tools and devices used in intravenous therapy, a medical procedure that involves delivering fluids, medications, or nutrients directly into a patient's bloodstream through a vein. IV therapy is commonly used for various purposes, including hydration, administering medications, blood transfusions and nutritional support. Examples of intravenous equipment include needles or catheters that are inserted into a vein to create access, flexible tubing’s that connects the IV bag or container to the patient and infusion pumps are electronic devices that control and regulate the flow rate, ensuring precise delivery.

The major factors driving the growth of the intravenous equipment market are the increase in number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV equipment technology. The demand for IV therapy is driven by the rising incidence of chronic diseases such cancer, diabetes, cardiovascular problems, and infectious diseases. Intravenous administration allows for the direct and efficient delivery of medications, fluids and nutrition, making it a crucial treatment method for patients with chronic conditions. In addition, world's population is experiencing a significant demographic shift, with a rapidly growing elderly population. The elderly people are more prone to developing chronic illnesses, which necessitate frequent hospital stays and medical treatment. IV therapy plays a vital role in providing supportive care to geriatric patients. Thus, the increasing geriatric population is contributing to the growth of the intravenous equipment market.

Further, continuous advancements in intravenous equipment technology have improved safety, precision and ease of use in administering intravenous therapy. Innovations such as smart infusion pumps, integrated connectivity solutions and needleless IV systems have enhanced the efficiency and accuracy of drug delivery, reduced the risk of medication errors and improved patient outcomes. Furthermore, growing awareness about the benefits of intravenous therapy, such as faster drug absorption, precise medication delivery and improved patient compliance, has increased among healthcare professionals and patients. Thus, more medical practitioners are incorporating IV therapy into their treatment plans, leading to a higher demand for intravenous equipment.

Additionally, as many nations invest more funds in enhancing healthcare infrastructure and boosting access to high-quality medical services, healthcare spending keeps rising. This increased healthcare spending encompasses the procurement of essential medical equipment, including IV equipment, to meet the growing demand for advanced patient care, thereby propelling the market growth. In addition, emergency departments and critical care units frequently rely on IV therapy to stabilize patients quickly and administer life-saving medications or fluids. The rising number of emergency care cases and trauma incidents worldwide has significantly contributed to the demand for IV equipment in these settings. IV equipment plays a vital role in delivering essential treatments promptly and efficiently, ensuring optimal patient outcomes in critical care scenarios.

The intravenous equipment market is segmented into product type, end user, and region. On the basis of product type, the market is categorized into IV catheters, infusion pumps, administration sets, needleless connectors, and others. Further, administration sets are classified into solution administration sets and blood administration sets. On the basis of end user, the market is segregated into hospital and clinics, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global intravenous equipment market are Becton, Dickinson and Company, B. Braun SE, ICU Medical, Inc., vygon, Baxter International Inc., Teleflex Incorporated., 3M Company, AngioDynamics, Inc., Terumo Corporation and Poly Medicure Ltd. The key players have adopted strategy such as product approval and acquisition to expand their product portfolio.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intravenous equipment market analysis from 2022 to 2032 to identify the prevailing intravenous equipment market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the intravenous equipment market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global intravenous equipment market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

● Regulatory Guidelines

● Additional company profiles with specific to client's interest

● Additional country or region analysis- market size and forecast

● Expanded list for Company Profiles

● Historic market data

● SWOT Analysis

Key Market Segments

○ Teleflex Incorporated

Scope of Intravenous Equipment Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. High bargaining power of suppliers

3.3.2. Moderate threat of new entrants

3.3.3. Moderate threat of substitutes

3.3.4. Low intensity of rivalry

3.3.5. High bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Technological advancements in intravenous equipment

3.4.1.2. Growing number of surgical procedures

3.4.1.3. Growing prevalence of chronic diseases

3.4.2. Restraints

3.4.2.1. Stringent regulatory requirements

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. IV catheters

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Infusion pumps

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Administration sets

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

4.4.4. Administration sets Intravenous Equipment Market by Type of set

4.5. Needleless connectors

4.5.1. Key market trends, growth factors and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market share analysis by country

4.6. Others

4.6.1. Key market trends, growth factors and opportunities

4.6.2. Market size and forecast, by region

4.6.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals and clinics

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Homecare settings

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast By Region

6.2. North America

6.2.1. Key trends and opportunities

6.2.2. Market size and forecast, by Product Type

6.2.3. Market size and forecast, by End User

6.2.4. Market size and forecast, by country

6.2.4.1. U.S.

6.2.4.1.1. Key market trends, growth factors and opportunities

6.2.4.1.2. Market size and forecast, by Product Type

6.2.4.1.3. Market size and forecast, by End User

6.2.4.2. Canada

6.2.4.2.1. Key market trends, growth factors and opportunities

6.2.4.2.2. Market size and forecast, by Product Type

6.2.4.2.3. Market size and forecast, by End User

6.2.4.3. Mexico

6.2.4.3.1. Key market trends, growth factors and opportunities

6.2.4.3.2. Market size and forecast, by Product Type

6.2.4.3.3. Market size and forecast, by End User

6.3. Europe

6.3.1. Key trends and opportunities

6.3.2. Market size and forecast, by Product Type

6.3.3. Market size and forecast, by End User

6.3.4. Market size and forecast, by country

6.3.4.1. Germany

6.3.4.1.1. Key market trends, growth factors and opportunities

6.3.4.1.2. Market size and forecast, by Product Type

6.3.4.1.3. Market size and forecast, by End User

6.3.4.2. France

6.3.4.2.1. Key market trends, growth factors and opportunities

6.3.4.2.2. Market size and forecast, by Product Type

6.3.4.2.3. Market size and forecast, by End User

6.3.4.3. UK

6.3.4.3.1. Key market trends, growth factors and opportunities

6.3.4.3.2. Market size and forecast, by Product Type

6.3.4.3.3. Market size and forecast, by End User

6.3.4.4. Italy

6.3.4.4.1. Key market trends, growth factors and opportunities

6.3.4.4.2. Market size and forecast, by Product Type

6.3.4.4.3. Market size and forecast, by End User

6.3.4.5. Spain

6.3.4.5.1. Key market trends, growth factors and opportunities

6.3.4.5.2. Market size and forecast, by Product Type

6.3.4.5.3. Market size and forecast, by End User

6.3.4.6. Rest of Europe

6.3.4.6.1. Key market trends, growth factors and opportunities

6.3.4.6.2. Market size and forecast, by Product Type

6.3.4.6.3. Market size and forecast, by End User

6.4. Asia-Pacific

6.4.1. Key trends and opportunities

6.4.2. Market size and forecast, by Product Type

6.4.3. Market size and forecast, by End User

6.4.4. Market size and forecast, by country

6.4.4.1. Japan

6.4.4.1.1. Key market trends, growth factors and opportunities

6.4.4.1.2. Market size and forecast, by Product Type

6.4.4.1.3. Market size and forecast, by End User

6.4.4.2. China

6.4.4.2.1. Key market trends, growth factors and opportunities

6.4.4.2.2. Market size and forecast, by Product Type

6.4.4.2.3. Market size and forecast, by End User

6.4.4.3. India

6.4.4.3.1. Key market trends, growth factors and opportunities

6.4.4.3.2. Market size and forecast, by Product Type

6.4.4.3.3. Market size and forecast, by End User

6.4.4.4. Australia

6.4.4.4.1. Key market trends, growth factors and opportunities

6.4.4.4.2. Market size and forecast, by Product Type

6.4.4.4.3. Market size and forecast, by End User

6.4.4.5. South Korea

6.4.4.5.1. Key market trends, growth factors and opportunities

6.4.4.5.2. Market size and forecast, by Product Type

6.4.4.5.3. Market size and forecast, by End User

6.4.4.6. Rest of Asia-Pacific

6.4.4.6.1. Key market trends, growth factors and opportunities

6.4.4.6.2. Market size and forecast, by Product Type

6.4.4.6.3. Market size and forecast, by End User

6.5. LAMEA

6.5.1. Key trends and opportunities

6.5.2. Market size and forecast, by Product Type

6.5.3. Market size and forecast, by End User

6.5.4. Market size and forecast, by country

6.5.4.1. Brazil

6.5.4.1.1. Key market trends, growth factors and opportunities

6.5.4.1.2. Market size and forecast, by Product Type

6.5.4.1.3. Market size and forecast, by End User

6.5.4.2. Saudi Arabia

6.5.4.2.1. Key market trends, growth factors and opportunities

6.5.4.2.2. Market size and forecast, by Product Type

6.5.4.2.3. Market size and forecast, by End User

6.5.4.3. South Africa

6.5.4.3.1. Key market trends, growth factors and opportunities

6.5.4.3.2. Market size and forecast, by Product Type

6.5.4.3.3. Market size and forecast, by End User

6.5.4.4. Rest of LAMEA

6.5.4.4.1. Key market trends, growth factors and opportunities

6.5.4.4.2. Market size and forecast, by Product Type

6.5.4.4.3. Market size and forecast, by End User

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Top player positioning, 2022

8.1. Becton, Dickinson and Company

8.1.1. Company overview

8.1.2. Key Executives

8.1.3. Company snapshot

8.1.4. Operating business segments

8.1.5. Product portfolio

8.1.6. Business performance

8.2. B. Braun SE

8.2.1. Company overview

8.2.2. Key Executives

8.2.3. Company snapshot

8.2.4. Operating business segments

8.2.5. Product portfolio

8.2.6. Business performance

8.3. ICU Medical, Inc.

8.3.1. Company overview

8.3.2. Key Executives

8.3.3. Company snapshot

8.3.4. Operating business segments

8.3.5. Product portfolio

8.3.6. Business performance

8.3.7. Key strategic moves and developments

8.4. Baxter International Inc.

8.4.1. Company overview

8.4.2. Key Executives

8.4.3. Company snapshot

8.4.4. Operating business segments

8.4.5. Product portfolio

8.4.6. Business performance

8.4.7. Key strategic moves and developments

8.5. Teleflex Incorporated.

8.5.1. Company overview

8.5.2. Key Executives

8.5.3. Company snapshot

8.5.4. Operating business segments

8.5.5. Product portfolio

8.5.6. Business performance

8.6. 3M Company

8.6.1. Company overview

8.6.2. Key Executives

8.6.3. Company snapshot

8.6.4. Operating business segments

8.6.5. Product portfolio

8.6.6. Business performance

8.7. AngioDynamics, Inc.

8.7.1. Company overview

8.7.2. Key Executives

8.7.3. Company snapshot

8.7.4. Operating business segments

8.7.5. Product portfolio

8.7.6. Business performance

8.8. Terumo Corporation

8.8.1. Company overview

8.8.2. Key Executives

8.8.3. Company snapshot

8.8.4. Operating business segments

8.8.5. Product portfolio

8.8.6. Business performance

8.9. Poly Medicure Ltd.

8.9.1. Company overview

8.9.2. Key Executives

8.9.3. Company snapshot

8.9.4. Operating business segments

8.9.5. Product portfolio

8.9.6. Business performance

8.10. Vygon

8.10.1. Company overview

8.10.2. Key Executives

8.10.3. Company snapshot

8.10.4. Operating business segments

8.10.5. Product portfoli

LIST OF TABLES

TABLE 01. GLOBAL INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 02. INTRAVENOUS EQUIPMENT MARKET FOR IV CATHETERS, BY REGION, 2022-2032 ($MILLION)

TABLE 03. INTRAVENOUS EQUIPMENT MARKET FOR INFUSION PUMPS, BY REGION, 2022-2032 ($MILLION)

TABLE 04. INTRAVENOUS EQUIPMENT MARKET FOR ADMINISTRATION SETS, BY REGION, 2022-2032 ($MILLION)

TABLE 05. GLOBAL ADMINISTRATION SETS INTRAVENOUS EQUIPMENT MARKET, BY TYPE OF SET, 2022-2032 ($MILLION)

TABLE 06. INTRAVENOUS EQUIPMENT MARKET FOR NEEDLELESS CONNECTORS, BY REGION, 2022-2032 ($MILLION)

TABLE 07. INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 08. GLOBAL INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 09. INTRAVENOUS EQUIPMENT MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)

TABLE 10. INTRAVENOUS EQUIPMENT MARKET FOR HOMECARE SETTINGS, BY REGION, 2022-2032 ($MILLION)

TABLE 11. INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)

TABLE 12. INTRAVENOUS EQUIPMENT MARKET, BY REGION, 2022-2032 ($MILLION)

TABLE 13. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 14. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 15. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 16. U.S. INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 17. U.S. INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 18. CANADA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 19. CANADA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 20. MEXICO INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 21. MEXICO INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 22. EUROPE INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 23. EUROPE INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 24. EUROPE INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 25. GERMANY INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 26. GERMANY INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 27. FRANCE INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 28. FRANCE INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 29. UK INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 30. UK INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 31. ITALY INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 32. ITALY INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 33. SPAIN INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 34. SPAIN INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 35. REST OF EUROPE INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 36. REST OF EUROPE INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 37. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 38. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 39. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 40. JAPAN INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 41. JAPAN INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 42. CHINA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 43. CHINA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 44. INDIA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 45. INDIA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 46. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 47. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 48. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 49. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 50. REST OF ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 51. REST OF ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 52. LAMEA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 53. LAMEA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 54. LAMEA INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)

TABLE 55. BRAZIL INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 56. BRAZIL INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 57. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 58. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 59. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 60. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 61. REST OF LAMEA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)

TABLE 62. REST OF LAMEA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)

TABLE 63. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES

TABLE 64. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 65. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS

TABLE 66. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO

TABLE 67. B. BRAUN SE: KEY EXECUTIVES

TABLE 68. B. BRAUN SE: COMPANY SNAPSHOT

TABLE 69. B. BRAUN SE: PRODUCT SEGMENTS

TABLE 70. B. BRAUN SE: PRODUCT PORTFOLIO

TABLE 71. ICU MEDICAL, INC.: KEY EXECUTIVES

TABLE 72. ICU MEDICAL, INC.: COMPANY SNAPSHOT

TABLE 73. ICU MEDICAL, INC.: PRODUCT SEGMENTS

TABLE 74. ICU MEDICAL, INC.: PRODUCT PORTFOLIO

TABLE 75. ICU MEDICAL, INC.: KEY STRATERGIES

TABLE 76. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES

TABLE 77. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 78. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS

TABLE 79. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 80. BAXTER INTERNATIONAL INC.: KEY STRATERGIES

TABLE 81. TELEFLEX INCORPORATED.: KEY EXECUTIVES

TABLE 82. TELEFLEX INCORPORATED.: COMPANY SNAPSHOT

TABLE 83. TELEFLEX INCORPORATED.: PRODUCT SEGMENTS

TABLE 84. TELEFLEX INCORPORATED.: PRODUCT PORTFOLIO

TABLE 85. 3M COMPANY: KEY EXECUTIVES

TABLE 86. 3M COMPANY: COMPANY SNAPSHOT

TABLE 87. 3M COMPANY: PRODUCT SEGMENTS

TABLE 88. 3M COMPANY: PRODUCT PORTFOLIO

TABLE 89. ANGIODYNAMICS, INC.: KEY EXECUTIVES

TABLE 90. ANGIODYNAMICS, INC.: COMPANY SNAPSHOT

TABLE 91. ANGIODYNAMICS, INC.: PRODUCT SEGMENTS

TABLE 92. ANGIODYNAMICS, INC.: PRODUCT PORTFOLIO

TABLE 93. TERUMO CORPORATION: KEY EXECUTIVES

TABLE 94. TERUMO CORPORATION: COMPANY SNAPSHOT

TABLE 95. TERUMO CORPORATION: PRODUCT SEGMENTS

TABLE 96. TERUMO CORPORATION: PRODUCT PORTFOLIO

TABLE 97. POLY MEDICURE LTD.: KEY EXECUTIVES

TABLE 98. POLY MEDICURE LTD.: COMPANY SNAPSHOT

TABLE 99. POLY MEDICURE LTD.: PRODUCT SEGMENTS

TABLE 100. POLY MEDICURE LTD.: PRODUCT PORTFOLIO

TABLE 101. VYGON: KEY EXECUTIVES

TABLE 102. VYGON: COMPANY SNAPSHOT

TABLE 103. VYGON: PRODUCT SEGMENTS

TABLE 104. VYGON: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. INTRAVENOUS EQUIPMENT MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF INTRAVENOUS EQUIPMENT MARKET,2022-2032

FIGURE 03. TOP INVESTMENT POCKETS IN INTRAVENOUS EQUIPMENT MARKET (2023-2032)

FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS

FIGURE 05. MODERATE THREAT OF NEW ENTRANTS

FIGURE 06. MODERATE THREAT OF SUBSTITUTES

FIGURE 07. LOW INTENSITY OF RIVALRY

FIGURE 08. HIGH BARGAINING POWER OF BUYERS

FIGURE 09. GLOBAL INTRAVENOUS EQUIPMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 10. INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR IV CATHETERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR INFUSION PUMPS, BY COUNTRY 2022 AND 2032(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR ADMINISTRATION SETS, BY COUNTRY 2022 AND 2032(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR NEEDLELESS CONNECTORS, BY COUNTRY 2022 AND 2032(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 16. INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR HOMECARE SETTINGS, BY COUNTRY 2022 AND 2032(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)

FIGURE 20. INTRAVENOUS EQUIPMENT MARKET BY REGION, 2022(%)

FIGURE 21. U.S. INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 22. CANADA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 23. MEXICO INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 24. GERMANY INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 25. FRANCE INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 26. UK INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 27. ITALY INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 28. SPAIN INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 29. REST OF EUROPE INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 30. JAPAN INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 31. CHINA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 32. INDIA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 33. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 34. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 35. REST OF ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 36. BRAZIL INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 37. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 38. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 39. REST OF LAMEA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)

FIGURE 40. TOP WINNING STRATEGIES, BY YEAR

FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 44. COMPETITIVE DASHBOARD

FIGURE 45. COMPETITIVE HEATMAP: INTRAVENOUS EQUIPMENT MARKET

FIGURE 46. TOP PLAYER POSITIONING, 2022

FIGURE 47. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 48. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 49. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 50. B. BRAUN SE: NET SALES, 2020-2022 ($MILLION)

FIGURE 51. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 52. B. BRAUN SE: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 53. ICU MEDICAL, INC.: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 54. ICU MEDICAL, INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 55. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)

FIGURE 56. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 57. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 58. 3M COMPANY: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 59. 3M COMPANY: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)

FIGURE 60. 3M COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 61. 3M COMPANY: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 62. ANGIODYNAMICS, INC.: NET SALES, 2020-2022 ($MILLION)

FIGURE 63. ANGIODYNAMICS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 64. ANGIODYNAMICS, INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 65. TERUMO CORPORATION: NET SALES, 2020-2022 ($MILLION)

FIGURE 66. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 67. TERUMO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 68. POLY MEDICURE LTD.: NET REVENUE, 2020-2022 ($MILLION